While Biodesix Inc has overperformed by 0.38%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BDSX fell by -81.31%, with highs and lows ranging from $2.04 to $0.17, whereas the simple moving average fell by -73.27% in the last 200 days.
On May 14, 2025, William Blair Downgraded Biodesix Inc (NASDAQ: BDSX) to Mkt Perform. A report published by Scotiabank on September 16, 2024, Initiated its previous ‘Sector Outperform’ rating for BDSX. Craig Hallum also rated BDSX shares as ‘Buy’, setting a target price of $3 on the company’s shares in an initiating report dated July 26, 2024. TD Cowen Initiated an Buy rating on May 13, 2024, and assigned a price target of $2.80. Lake Street initiated its ‘Buy’ rating for BDSX, as published in its report on May 03, 2024. Morgan Stanley’s report from November 17, 2021 suggests a price prediction of $11 for BDSX shares, giving the stock a ‘Equal-Weight’ rating. William Blair also rated the stock as ‘Outperform’.
Analysis of Biodesix Inc (BDSX)
Further, the quarter-over-quarter increase in sales is 21.19%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Biodesix Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -1454.41% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.14, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 8.49M can be a very valuable indicator of volatility for BDSX stock. On a monthly basis, the volatility of the stock is set at 10.52%, whereas on a weekly basis, it is put at 2.85%, with a loss of -0.66% over the past seven days. Furthermore, long-term investors anticipate a median target price of $1.80, showing growth from the present price of $0.29, which can serve as yet another indication of whether BDSX is worth investing in or should be passed over.
How Do You Analyze Biodesix Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 52.65%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 36.42% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
BDSX shares are owned by institutional investors to the tune of 36.42% at present.
